Search Info: P00533-Tyr1068 & status=Reviewed
Total related records: 32
Record | Protein | Protein id | Symbol | PTM type | Site | Species | Disease | Cell line | Drug | Regulatory | Confidence score(level) | Ref. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
acc1102 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc0764 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Prostate Cancer | PC3 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc1610 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-9 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1629 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | CL1-5 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc1649 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Pancreas Cancer | L3.6pl | Gefitinib | Associated | 4.0 (Moderate) | 16585207 |
acc0920 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H2286 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc1632 | EGFR | P00533 | EGFR | ubiquitination | Tyr1068 | human | Lung Cancer | CL1-5 | Gefitinib | Enhancing | 5.0 (High) | 21858220 |
acc0613 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Ovarian Cancer | COC1/DDP | DDP | Impairing | 5.0 (High) | 33794187 |
acc4589 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Retinoblastoma | Y-79 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc1620 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | Erlotinib | Enhancing | 5.0 (High) | 26247735 | |
acc1101 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc4687 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc1667 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HuH6 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1608 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-6 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1634 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Head and Neck Cancer | Lysophosphatidic acid (LPA) | Associated | 4.0 (Moderate) | 12414665 | |
acc0766 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Prostate Cancer | DU145 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc1622 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | A549 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1666 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | Hep3B | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc0099 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc1630 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | A549 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc0612 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Ovarian Cancer | A2780/DDP | DDP | Impairing | 5.0 (High) | 33794187 |
acc1665 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1633 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | PC9 | Docetaxel + Gefitinib | Associated | 4.0 (Moderate) | 24682085 |
acc1625 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc0616 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0921 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | HCC366 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc1668 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | PLC/PRF5 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc0630 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc1609 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-9 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc4593 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Retinoblastoma | WERI-Rb-1 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc1631 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc1621 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | CL1-5 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |